col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


56 Results       Page 1

 [1] 
Ovid: Neurology Neuroimmunology & Neuroinflammation
  original article Date Title Authors   All Authors
1 [GO] 2023―Feb―17 Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis Gertjan Peeters, Ann Van Remoortel, Guy Nagels, Jeroen Van Schependom, Miguel D'haeseleer
2 [GO] 2023―Jan―24 Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases Martin W. Hümmert, Franziska Bütow, Daria Tkachenko, Ilya Ayzenberg, Thivya Pakeerathan, Kerstin Hellwig, et al. (+31)
3 [GO] 2022―Nov―21 Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination Anna G. Francis, Kariem Elhadd, Valentina Camera, Monica Ferreira dos Santos, Chiara Rocchi, Poneh Adib-Samii, et al. (+17)
4 [GO] 2022―Nov―17 Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year Giulio Disanto, Alice Galante, Marco Cantu', Rosaria Sacco, Federico Mele, Jennifer Jessica Eisler, et al. (+5)
5 [GO] 2022―Oct―12 Timing of SARS-CoV-2 Vaccination Matters in People With Multiple Sclerosis on Pulsed Anti-CD20 Treatment Christina Woopen, Marie Dunsche, Rocco Haase, Catarina Raposo, Rosetta Pedotti, Katja Akgün, Tjalf Ziemssen
6 [GO] 2022―Aug―29 Updated Results of the COVID-19 in MS Global Data Sharing Initiative Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, Edward De Brouwer, Lotte Geys, Tina Parciak, et al. (+39)
7 [GO] 2022―Aug―26 Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
8 [GO] 2022―Jun―21 Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis David Reyes-Leiva, Joaquín López-Contreras, Esther Moga, Francesc Pla-Juncà, Elionor Lynton-Pons, Ricardo Rojas-Garcia, et al. (+11)
9 [GO] 2022―Jun―21 Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology Marinos C. Dalakas, Josep Dalmau
10 [GO] 2022―Jun―14 Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection Michael J. Peluso, Hannah M. Sans, Carrie A. Forman, Alyssa N. Nylander, Hsi-en Ho, Scott Lu, et al. (+19)
11 [GO] 2022―May―06 Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod Virginia Palomares Cabeza, Laura Y.L. Kummer, Luuk Wieske, Ruth R. Hagen, Mariel Duurland, Veronique A.L. Konijn, et al. (+15)
12 [GO] 2022―Mar―07 Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection Barbara A. Hanson, Lavanya Visvabharathy, Sareen T. Ali, Anthony K. Kang, Tulsi R. Patel, Jeffrey R. Clark, et al. (+7)
13 [GO] 2022―Feb―01 Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis Ana Zabalza, Georgina Arrambide, Paula Tagliani, Simón Cárdenas-Robledo, Susana Otero-Romero, Juliana Esperalba, et al. (+27)
14 [GO] 2022―Jan―19 Risk of Getting COVID-19 in People With Multiple Sclerosis Pietro Iaffaldano, Giuseppe Lucisano, Alessia Manni, Damiano Paolicelli, Francesco Patti, Marco Capobianco, et al. (+28)
15 [GO] 2021―Nov―30 Recovery From COVID-19 in Multiple Sclerosis Afagh Garjani, Rodden M. Middleton, Richard Nicholas, Nikos Evangelou
16 [GO] 2021―Nov―30 COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients Roseanne Sullivan, Ajay Kilaru, Bernhard Hemmer, Bruce Anthony Campbell Cree, Benjamin M. Greenberg, Uma Kundu, et al. (+4)
17 [GO] 2021―Nov―10 Impact of COVID-19 in Immunosuppressed Children With Neuroimmunologic Disorders Gemma Olivé-Cirera, Elianet Fonseca, Verónica Cantarín-Extremera, María Vázquez-López, María Jiménez-Legido, Verónica González-Álvarez, et al. (+7)
18 [GO] 2021―Nov―10 Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA Vaccine Michael Yu Sy, Erin Fromm, Linda Doan, Nathan Rojek, Alexander Ulrich Brandt
19 [GO] 2021―Nov―09 COVID-19 Severity in Multiple Sclerosis Maria Pia Sormani, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Massimo Filippi, Marta Radaelli, et al. (+20)
20 [GO] 2021―Nov―09 COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis Farren Basil Shaw Briggs, Farrah J. Mateen, Hollie Schmidt, Keisha M. Currie, Heather M. Siefers, Slavka Crouthamel, et al. (+8)
21 [GO] 2021―Sep―08 Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic Martin S. Weber, Jacqueline A. Nicholas, Michael R. Yeaman
22 [GO] 2021―Aug―27 Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19 Giovanna S. Manzano, Caleb R. S. McEntire, Maria Martinez-Lage, Farrah J. Mateen, Spencer K. Hutto
23 [GO] 2021―Aug―26 Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders Samira Luisa Apostolos-Pereira, Lis Campos Ferreira, Mateus Boaventura, Nise Alessandra de Carvalho Sousa, Gabriela Joca Martins, José Arthur d'Almeida, et al. (+62)
24 [GO] 2021―Aug―24 COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America Scott D. Newsome, Anne H. Cross, Robert J. Fox, June Halper, Pamela Kanellis, Bruce Bebo, et al. (+4)
25 [GO] 2021―Aug―02 A New England COVID-19 Registry of Patients With CNS Demyelinating Disease Kelli M. Money, Ashmanie Mahatoo, Soleil Samaan, Pria Anand, Ursela Baber, Mary Bailey, et al. (+14)
26 [GO] 2021―Jul―28 CNS Lymphocytic Vasculitis in a Young Woman With COVID-19 Infection Garrett M. Timmons, Torge Rempe, Elizabeth A. Bevins, Vanessa Goodwill, Annalise Miner, Arthur Kavanaugh, et al. (+2)
27 [GO] 2021―Jul―14 Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19 Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, Christopher Nelke, Anke Lux, Refik Pul, et al. (+15)
28 [GO] 2021―Jul―02 COVID-19 Among Patients With Multiple Sclerosis
29 [GO] 2021―Jun―24 SARS-CoV-2 Infection in Multiple Sclerosis Georgina Arrambide, Miguel Ángel Llaneza-González, Lucienne Costa-Frossard França, Virginia Meca-Lallana, Eva Fernández- Díaz, Irene Moreno-Torres, et al. (+34)
30 [GO] 2021―Jun―16 Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation Raphael Bernard-Valnet, Sylvain Perriot, Mathieu Canales, Beatrice Pizzarotti, Leonardo Caranzano, Mayté Castro-Jiménez, et al. (+11)
31 [GO] 2021―May―21 Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2
32 [GO] 2021―May―20 COVID-19 Among Patients With Multiple Sclerosis Mahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, Alireza Afshari-Safavi, Nasim Nehzat, Saeed Vaheb, et al. (+2)
33 [GO] 2021―Apr―14 Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2 Mario Sa, Luwaiza Mirza, Michael Carter, Lalani Carlton Jones, Vasantha Gowda, Jennifer Handforth, et al. (+15)
34 [GO] 2021―Jan―27 Presence of SARS-CoV-2 Transcripts in the Choroid Plexus of MS and Non-MS Patients With COVID-19 Vidmante Fuchs, Michael Kutza, Sven Wischnewski, Nikolaus Deigendesch, Luc Lutz, Laila Kulsvehagen, et al. (+7)
35 [GO] 2021―Jan―27 Incidence and Impact of COVID-19 in MS Maria Sepúlveda, Sara Llufriu, Eugenia Martínez-Hernández, Martí Català, Montse Artola, Ana Hernando, et al. (+12)
36 [GO] 2020―Dec―16 Acute disseminated encephalomyelitis after SARS-CoV-2 infection
37 [GO] 2020―Dec―11 Presentations and mechanisms of CNS disorders related to COVID-19 Marta Bodro, Yaroslau Compta, Raquel Sánchez-Valle
38 [GO] 2020―Aug―21 N2 in the time of COVID-19 Josep Dalmau
39 [GO] 2020―Aug―13 Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency Steffen Pfeuffer, Matthias Pawlowski, Gunther S. Joos, Jens Minnerup, Sven G. Meuth, Rainer Dziewas, Heinz Wiendl
40 [GO] 2020―Jul―10 COVID-19 outcomes in MS Erica Parrotta, Ilya Kister, Leigh Charvet, Carrie Sammarco, Valerie Saha, Robert Erik Charlson, et al. (+9)
41 [GO] 2020―Jul―10 Guillain-Barré syndrome related to SARS-CoV-2 infection
42 [GO] 2020―Jul―02 Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2-associated encephalitis Marta Bodro, Yaroslau Compta, Laura Llansó, Diana Esteller, Antonio Doncel-Moriano, Alex Mesa, et al. (+11)
43 [GO] 2020―Jun―26 Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond? Adil Maarouf, Audrey Rico, Clemence Boutiere, Marine Perriguey, Sarah Demortiere, Jean Pelletier, Bertrand Audoin
44 [GO] 2020―Jun―26 COVID-19-associated ophthalmoparesis and hypothalamic involvement Elba Pascual-Goñi, Juan Fortea, Alejandro Martínez-Domeño, Nuria Rabella, Mario Tecame, Cristina Gómez-Oliva, et al. (+2)
45 [GO] 2020―Jun―12 Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019? Cole Maguire, Teresa Frohman, Scott S. Zamvil, Elliot Frohman, Esther Melamed
46 [GO] 2020―Jun―11 CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19 Ashwin A. Pinto, Liam S. Carroll, Vijay Nar, Aravinthan Varatharaj, Ian Galea
47 [GO] 2020―Jun―11 COVID-19-associated acute necrotizing myelitis Javier Sotoca, Yensa Rodríguez-Álvarez
48 [GO] 2020―Jun―10 Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease Marinos C. Dalakas
49 [GO] 2020―Jun―05 Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19 Ahmed Elkady, Alejandro A. Rabinstein
50 [GO] 2020―Jun―05 Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders Moli Fan, Wei Qiu, Bitao Bu, Yan Xu, Huan Yang, Dehui Huang, et al. (+10)
51 [GO] 2020―Jun―02 Acute disseminated encephalomyelitis after SARS-CoV-2 infection Giovanni Novi, Tommaso Rossi, Enrico Pedemonte, Laura Saitta, Claudia Rolla, Luca Roccatagliata, et al. (+2)
52 [GO] 2020―May―28 Guillain-Barré syndrome related to SARS-CoV-2 infection Kévin Bigaut, Martial Mallaret, Seyyid Baloglu, Benjamin Nemoz, Patrice Morand, Florent Baicry, et al. (+5)
53 [GO] 2020―May―23 COVID-19-White matter and globus pallidum lesions Gilles Brun, Jean-François Hak, Stéphanie Coze, Elsa Kaphan, Julien Carvelli, Nadine Girard, Jan-Patrick Stellmann
54 [GO] 2020―May―16 COVID-19 and MS disease-modifying therapies Joseph R. Berger, Rachel Brandstadter, Amit Bar-Or
55 [GO] 2020―May―06 COVID-19 infection in a patient with multiple sclerosis treated with fingolimod Mahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, Reza Sarrafi, Farzin Khorvash, Amir-Hadi Maghzi, Vahid Shaygannejad
56 [GO] 2020―Apr―30 Guillain-Barré syndrome related to COVID-19 infection Paola Alberti, Simone Beretta, Marco Piatti, Aristotelis Karantzoulis, Maria Luisa Piatti, Patrizia Santoro, et al. (+6)
 [1] 

56 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.013 sec